Smith RJ et al. |
Effects of an anion channel blocker, 4, 4'-diisothiocyano-2,2'-disulfonic acid stilbene (DIDS), on human neutrophil function. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6329191
|
Haye B et al. |
Interactions between thyreostimulin and PAF-acether on thyroid cell metabolism. |
1984 |
Eur. J. Pharmacol. |
pmid:6094205
|
Gordeev KIu et al. |
[A bioregulator of lipid nature--a platelet activating factor (PAF)]. |
1984 |
Bioorg. Khim. |
pmid:6099122
|
Wang ZY |
[Advances in the physiopathology of platelets]. |
1984 |
Zhonghua Nei Ke Za Zhi |
pmid:6099795
|
Clay KL et al. |
Structure elucidation of platelet activating factor derived from human neutrophils. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6430285
|
Nishihira J et al. |
Production and characterization of specific antibodies against 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a potent hypotensive and platelet-activating ether-linked phospholipid). |
1984 |
J. Biochem. |
pmid:6430883
|
Knauer KA et al. |
Platelet augmentation of IgE-dependent histamine release from human basophils and mast cells. |
1984 |
Int. Arch. Allergy Appl. Immunol. |
pmid:6200443
|
Kazimierczak W et al. |
Deuterium-oxide-induced histamine release from basophils of allergic subjects. I. Responsiveness to deuterium oxide requires an activation step. |
1984 |
Am. Rev. Respir. Dis. |
pmid:6201094
|
Feuerstein G et al. |
Hypotension produced by platelet-activating factor is reversed by thyrotropin-releasing hormone. |
1984 |
Circ. Shock |
pmid:6432359
|
Parnham MJ et al. |
Regulation of the oxidative burst of macrophages by lipid mediators. |
1984 |
Agents Actions Suppl. |
pmid:6433680
|
O'Flaherty JT et al. |
Diacylglycerols enhance human neutrophil degranulation responses: relevancy to a multiple mediator hypothesis of cell function. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6433920
|
Mendlovic F et al. |
Possible involvement of cyclooxygenase products in the actions of platelet-activating factor and of lipoxygenase products in the vascular effects of epinephrine in perfused rat liver. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6435614
|
Fouque F and Vargaftig BB |
Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation. |
1984 |
Br. J. Pharmacol. |
pmid:6439269
|
Karlsson G and Pipkorn U |
Effect of disodium chromoglycate on changes in nasal airway resistance induced by platelet activating factor. |
1984 |
Eur. J. Clin. Pharmacol. |
pmid:6439565
|
Nakamura N et al. |
Synthesis and biological activities of bioisosteric O-carba-analogues of platelet activating factor (PAF). |
1984 |
Chem. Pharm. Bull. |
pmid:6488414
|
Sakamoto H et al. |
Stimulation of leukocyte phagocytic activity by the platelet release reaction. |
1984 |
Pathology |
pmid:6462776
|
Shukla SD and Hanahan DJ |
Acetylglyceryl ether phosphorylcholine (AGEPC; platelet-activating factor)-induced stimulation of rabbit platelets: correlation between phosphatidic acid level, 45Ca2+ uptake, and [3H]serotonin secretion. |
1984 |
Arch. Biochem. Biophys. |
pmid:6465886
|
Doebber TW et al. |
Platelet activating factor intravenous infusion in rats stimulates vascular lysosomal hydrolase secretion independent of blood neutrophils. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6517949
|
Heinrich J and Zimmermann RE |
Compound 48/80 is a potent inhibitor of human platelet aggregation antagonizing the calmodulin-dependent platelet reaction in vitro. |
1984 |
Thromb. Res. |
pmid:6523451
|
Albert DH and Snyder F |
Release of arachidonic acid from 1-alkyl-2-acyl-sn-glycero-3-phosphocholine, a precursor of platelet-activating factor, in rat alveolar macrophages. |
1984 |
Biochim. Biophys. Acta |
pmid:6435681
|
Basran GS et al. |
Platelet-activating factor: a possible mediator of the dual response to allergen? |
1984 |
Clin. Allergy |
pmid:6697475
|
Kelton JG et al. |
Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopenia. |
1984 |
J. Lab. Clin. Med. |
pmid:6699475
|
Feuerstein G et al. |
Effect of platelet-activating factor on coronary circulation of the domestic pig. |
1984 |
Am. J. Physiol. |
pmid:6703081
|
Pipkorn U et al. |
Effect of platelet activating factor on the human nasal mucosa. |
1984 |
Allergy |
pmid:6703263
|
Lüthje J and Ogilvie A |
Diadenosine triphosphate (Ap3A) mediates human platelet aggregation by liberation of ADP. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6704102
|
Clare KA and Scrutton MC |
The role of Ca2+ uptake in the response of human platelets to adrenaline and to 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor). |
1984 |
Eur. J. Biochem. |
pmid:6705791
|
Denburg JA et al. |
Platelet activating factor: regulation by mast cells and aspirin. |
1984 |
Agents Actions |
pmid:6711391
|
El Tamer A et al. |
Studies on ether phospholipids. I. A new method of determination using phospholipase A1 from guinea pig pancreas: application to Krebs II ascites cells. |
1984 |
Biochim. Biophys. Acta |
pmid:6712966
|
Touqui L et al. |
Dissociation between inhibition of phospholipid methylation and production of PAF-acether by rabbit platelets. |
1984 |
Experientia |
pmid:6714369
|
Masugi F et al. |
[Etiological studies of hypertension. G. APRL (antihypertensive polar renomedullary lipid)]. |
1984 |
Nippon Rinsho |
pmid:6716685
|
Kester M et al. |
The potentiation of arterial contraction with platelet activating factor. |
1984 |
Pflugers Arch. |
pmid:6718228
|
Pelczar-Wissner CJ et al. |
Absence of platelet activating factor (PAF) mediated platelet aggregation: a new platelet defect. |
1984 |
Am. J. Hematol. |
pmid:6720685
|
Guay DR and Richard A |
Heparin-induced thrombocytopenia--association with a platelet aggregating factor and cross-sensitivity to bovine and porcine heparin. |
1984 |
Drug Intell Clin Pharm |
pmid:6723517
|
Kawaguchi H and Yasuda H |
Platelet-activating factor stimulates phospholipase in quiescent Swiss mouse 3T3 fibroblast. |
1984 |
FEBS Lett. |
pmid:6436057
|
Kramer RM et al. |
Metabolism of platelet-activating factor in human platelets. Transacylase-mediated synthesis of 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. |
1984 |
J. Biol. Chem. |
pmid:6436245
|
Andreesen R et al. |
Tumor cytotoxicity of human macrophages after incubation with synthetic analogues of 2-lysophosphatidylcholine. |
1984 |
J. Natl. Cancer Inst. |
pmid:6582303
|
Prescott SM et al. |
Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin. |
1984 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:6587368
|
Iñarrea P et al. |
Characteristics of the binding of platelet-activating factor to platelets of different animal species. |
1984 |
Eur. J. Pharmacol. |
pmid:6510472
|
Kornecki E et al. |
Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines. |
1984 |
Science |
pmid:6150550
|
Chignard M et al. |
Paf-acether formation and arachidonic acid freeing from platelet ether-linked glyceryl-phosphorylcholine. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6437404
|
Mojarad M et al. |
Platelet-activating factor increases pulmonary microvascular permeability and induces pulmonary edema. A preliminary report. |
1983 May-Jun |
Bull Eur Physiopathol Respir |
pmid:6882949
|
Pazzi A et al. |
[Platelet activation in vivo. Electron microscopy study of a case of type II diabetes]. |
1983 Mar-Apr |
G Clin Med |
pmid:6884636
|
Satouchi K et al. |
Application of selected ion monitoring to determination of platelet-activating factor. |
1983 |
J. Biochem. |
pmid:6423622
|
Hillmar I and Zöllner N |
Saturated and unsaturated 1-0-alkyl-2-0-acetoyl-sn-glycero-3-phosphocholines and 2-lyso derivatives from ratfish liver oil. Effect on adenosine 3':5'-cyclic monophosphate concentration in hepatocyte suspensions. |
1983 |
Res Exp Med (Berl) |
pmid:6310713
|
Mauco G et al. |
Platelet activating factor (PAF-acether) promotes an early degradation of phosphatidylinositol-4,5-biphosphate in rabbit platelets. |
1983 |
FEBS Lett. |
pmid:6311620
|
Camussi G et al. |
Release of platelet activating factor in rabbits with antibody-mediated injury of the lung: the role of leukocytes and of pulmonary endothelial cells. |
1983 |
J. Immunol. |
pmid:6311899
|
Hwang SB et al. |
Specific receptor sites for 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) on rabbit platelet and guinea pig smooth muscle membranes. |
1983 |
Biochemistry |
pmid:6313047
|
Shukla SD and Hanahan DJ |
An early transient decrease in phosphatidylinositol 4,5-bisphosphate upon stimulation of rabbit platelets with acetylglycerylether phosphorylcholine (platelet activating factor). |
1983 |
Arch. Biochem. Biophys. |
pmid:6320731
|
McManus LM et al. |
Thromboxane B2 (TxB2) release following acetyl glyceryl ether phosphorylcholine (AGEPC) infusion in the rabbit. |
1983 |
Immunopharmacology |
pmid:6832960
|
Jouvin-Marche E et al. |
Effect of the Ca2+ antagonist nifedipine on the release of platelet-activating factor (PAF-acether), slow-reacting substance and beta-glucuronidase from human neutrophils. |
1983 |
Eur. J. Pharmacol. |
pmid:6134631
|
Sano K et al. |
A role of calcium-activated phospholipid-dependent protein kinase in human platelet activation. Comparison of thrombin and collagen actions. |
1983 |
J. Biol. Chem. |
pmid:6218169
|
Vargaftig BB et al. |
Synergized activation of human platelets by epinephrine and platelet-activating factor-acether is adenosine diphosphate and thromboxane A2-independent. |
1983 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:6221558
|
Voelkel NF et al. |
Platelet-activating factor causes pulmonary vasoconstriction and edema via platelet-independent leukotriene formation. |
1983 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:6221590
|
Kloprogge E et al. |
Properties of PAF-acether-induced platelet aggregation and secretion. Studies in gel-filtered human platelets. |
1983 |
Thromb. Res. |
pmid:6222507
|
Bessin P et al. |
Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogs. |
1983 |
Eur. J. Pharmacol. |
pmid:6687572
|
Mueller HW et al. |
1-O-alkyl-linked phosphoglycerides of human platelets: distribution of arachidonate and other acyl residues in the ether-linked and diacyl species. |
1983 |
Lipids |
pmid:6419001
|
Shukla SD et al. |
Acetylglyceryl ether phosphorylcholine. A potent activator of hepatic phosphoinositide metabolism and glycogenolysis. |
1983 |
J. Biol. Chem. |
pmid:6309795
|
Hallam TJ et al. |
The role of 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (AcGEPC) and palmitoyl-lysophosphatidate in the responses of human blood platelets to collagen and thrombin. |
1983 |
FEBS Lett. |
pmid:6617886
|
Roussi J et al. |
[Success of treatment with a low-molecular-weight heparin fraction in a case of pulmonary embolism complicated by heparin-induced thrombopenia]. |
1983 |
Nouv Rev Fr Hematol |
pmid:6622253
|
Valone FH and Goetzl EJ |
Enhancement of human polymorphonuclear leukocyte adherence by the phospholipid mediator 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphorylcholine (AGEPC). |
1983 |
Am. J. Pathol. |
pmid:6624880
|
Barradas MA et al. |
The effect of fenfluramine on collagen-induced platelet aggregation in vitro. |
1983 |
Br J Clin Pharmacol |
pmid:6626443
|
Korth R et al. |
1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholines: influence on aggregation and [3H]serotonin release of human thrombocytes. |
1983 |
Chem. Phys. Lipids |
pmid:6627525
|
Moschidis MC et al. |
Phosphono-platelet activating factor I. Synthesis of 1-O-hexadecyl-2-O-acetyl-glyceryl-3-(2-trimethyl ammonium-methyl) phosphonate and its platelet activating potency. |
1983 |
Chem. Phys. Lipids |
pmid:6627527
|
Heffner JE et al. |
Acetyl glyceryl ether phosphorylcholine-stimulated human platelets cause pulmonary hypertension and edema in isolated rabbit lungs. Role of thromboxane A2. |
1983 |
J. Clin. Invest. |
pmid:6822668
|
Vargaftig BB et al. |
Convulxin-induced activation of intact and of thrombin-degranulated rabbit platelets: specific crossed desensitisation with collagen. |
1983 |
Eur. J. Pharmacol. |
pmid:6628537
|
Keraly CL et al. |
Effect of structural analogues of PAF-acether on platelet desensitization. |
1983 |
Br. J. Haematol. |
pmid:6824590
|
Farr RS et al. |
Human serum acid-labile factor is an acylhydrolase that inactivates platelet-activating factor. |
1983 |
Fed. Proc. |
pmid:6628702
|
Tence M et al. |
The enantiomer and the positional isomer of platelet-activating factor. |
1983 |
Biochim. Biophys. Acta |
pmid:6824744
|
Denjean A et al. |
Acute effects of intratracheal administration of platelet-activating factor in baboons. |
1983 |
J Appl Physiol Respir Environ Exerc Physiol |
pmid:6629917
|
Camussi G et al. |
Biosynthesis and release of platelet-activating factor from human monocytes. |
1983 |
Int. Arch. Allergy Appl. Immunol. |
pmid:6826235
|
Randolph AE et al. |
Blood pressure and heart rate effects of alkyl ether phospholipids in conscious renal, spontaneously hypertensive, and normotensive rats. |
1983 |
Clin Exp Hypertens A |
pmid:6684006
|
Morley J et al. |
Inflammatory actions of platelet activating factor (Pafacether) in guinea-pig skin. |
1983 |
Br. J. Pharmacol. |
pmid:6685552
|
Hornby EJ and Perry CR |
1-O-hexadecyl-2-acetyl-sn-3-glycerophosphorylcholine (PAF): some effects on the aggregation of human platelets by thrombin or collagen. |
1983 |
Thromb. Haemost. |
pmid:6636035
|
Patterson R and Harris KE |
The activity of aerosolized and intracutaneous synthetic platelet activating factor (AGEPC) in rhesus monkeys with IgE-mediated airway responses and normal monkeys. |
1983 |
J. Lab. Clin. Med. |
pmid:6644157
|
Nunn B |
Total and selective desensitisation of human platelets to synthetic platelet activating factor (PAF): evidence that extracellular PAF does not mediate collagen-induced aggregation. |
1983 |
Thromb. Res. |
pmid:6648898
|
Myers A et al. |
Glucocorticoid protection against PAF-acether toxicity in mice. |
1983 |
Br. J. Pharmacol. |
pmid:6652344
|
Cervoni P et al. |
Aortic vascular and atrial responses to (+/-)-1-O-octadecyl-2-acetyl-glyceryl-3-phosphorylcholine. |
1983 |
Br. J. Pharmacol. |
pmid:6652348
|
Benveniste J et al. |
The actions of Paf-acether (platelet-activating factor) on guinea-pig isolated heart preparations. |
1983 |
Br. J. Pharmacol. |
pmid:6652376
|
Garcia Gil M and Sanchez Crespo M |
Dansylcadaverine and rimantadine inhibition of phagocytosis, PAF-acether release, and phosphatidylcholine synthesis in human polymorphonuclear leukocytes. |
1983 |
Immunopharmacology |
pmid:6654649
|
Tokumura A et al. |
Biphasic action of platelet-activating factor on isolated guinea-pig ileum. |
1983 |
Lipids |
pmid:6656539
|
Hamasaki Y et al. |
[Effects of platelet activating factor (PAF:AGEPC) on airway and pulmonary vascular constriction of guinea pigs--with special reference to the relation with TXA2]. |
1983 |
Kokyu To Junkan |
pmid:6658209
|
Björk J et al. |
Paf-acether (platelet-activating factor) increases microvascular permeability and affects endothelium-granulocyte interaction in microvascular beds. |
1983 |
Acta Physiol. Scand. |
pmid:6659994
|
Björk J and Smedegård G |
Acute microvascular effects of PAF-acether, as studied by intravital microscopy. |
1983 |
Eur. J. Pharmacol. |
pmid:6662199
|
Holt PG et al. |
Platelet serotonin release by human polymorphonuclear leucocytes stimulated by cotton dust bacteria. |
1983 |
Clin. Exp. Immunol. |
pmid:6831770
|
Yamashita M et al. |
The metabolism of platelet activating factor in platelets and plasma of various animals. |
1983 |
J Toxicol Sci |
pmid:6663653
|
McDonald TP and Kalmaz GD |
Effects of thrombopoietin on the number and diameter of marrow megakaryocytes of mice. |
1983 |
Exp. Hematol. |
pmid:6832243
|
Masugi F et al. |
[Kidney medulla and hypertension, with special reference to antihypertensive lipids]. |
1983 |
Nihon Jinzo Gakkai Shi |
pmid:6663856
|
Lewis JC et al. |
Platelet-activating factor effects on pulmonary ultrastructure in rabbits. |
1983 |
Exp. Mol. Pathol. |
pmid:6832335
|
Levy JV |
Calmodulin antagonists inhibit aggregation of human, guniea pig and rabbit platelets induced with platelet activating factor. |
1983 |
FEBS Lett. |
pmid:6832368
|
Touqui L et al. |
Conversion of 3H-PAF acether by rabbit platelets is independent from aggregation: evidences for a novel metabolite. |
1983 |
Biochem. Biophys. Res. Commun. |
pmid:6838557
|
Worthen GS et al. |
Platelet-activating factor causes neutrophil accumulation and edema in rabbit lungs. |
1983 |
Chest |
pmid:6839840
|
Heffner JE et al. |
Platelet-induced pulmonary hypertension and edema. A mechanism involving acetyl glyceryl ether phosphorylcholine and thromboxane A2. |
1983 |
Chest |
pmid:6839854
|
Levy JV |
Calmodulin antagonist W-7 inhibits aggregation of human platelets induced by platelet activating factor. |
1983 |
Proc. Soc. Exp. Biol. Med. |
pmid:6844347
|
O'Flaherty JT et al. |
Platelet-activating factor and analogues: comparative studies with human neutrophils and rabbit platelets. |
1983 |
Res. Commun. Chem. Pathol. Pharmacol. |
pmid:6844746
|
Virella G et al. |
Release of PAF by human polymorphonuclear leucocytes stimulated by immune complexes bound to Sepharose particles and human erythrocytes. |
1983 |
Immunology |
pmid:6885111
|
Camussi G et al. |
Platelet-activating factor-mediated contraction of rabbit lung strips: pharmacologic modulation. |
1983 |
Immunopharmacology |
pmid:6885382
|
O'Flaherty JT and Wykle RL |
Biology and biochemistry of platelet-activating factor. |
1983 |
Clin Rev Allergy |
pmid:6370406
|
Tiffany ML |
Technical considerations for platelet aggregation and related problems. |
1983 |
Crit Rev Clin Lab Sci |
pmid:6370596
|
Vermylen J et al. |
Normal mechanisms of platelet function. |
1983 |
Clin Haematol |
pmid:6301715
|
Bonnet J et al. |
Dependency of the Paf-acether induced bronchospasm on the lipoxygenase pathway in the guinea-pig. |
1983 |
Prostaglandins |
pmid:6419289
|